Millions of older people are getting tests they don't need to prove they are healthy enough to have cataracts removed, a new study finds. The excess testing before this quick, ultra-safe eye procedure is costing them and Medicare a bundle, and many patients don't know they can question it, doctors say.
Consumers are one step closer to benefiting from packaging that could give simple text warnings...
Separating circulating cancer cells from blood cells for diagnostic, prognostic and treatment...
By looking at the molecular aftermath of concussion in an unusual way, a team of researchers at Brown Univ. and the Lifespan health system has developed a candidate panel of blood biomarkers that can accurately signal mild traumatic brain injury within hours using standard, widely available lab arrays. The results appear in the Journal of Neurotrauma.
Ancient malaria patients, the anthropologist will see you now. A Yale Univ. scientist has developed a promising new method to identify malaria in the bone marrow of ancient human remains. It is the first time researchers have been able to establish a diagnostic, human skeletal profile for the disease, which is transmitted by mosquitoes and continues to infect millions of people a year.
Long the stuff of science fiction, the disembodied “brain in a jar” is providing science fact for a team of researchers, who, by studying the whole brains of fruit flies, are discovering the inner mechanisms of jet lag.
This professor carries out pioneering work in the creation of biological circuits.
While today’s human body contains a variety of these proteins, a marine sciences professor believes they evolved from a single ancestor millions of years ago. This find is pivotal in unraveling the mysteries of DNA organization and regulation, and could someday lead to innovative biomonitoring strategies and therapies targeting a variety of diseases including cancer.
A team of Yale Univ. researchers has developed a simple method that could significantly reduce the time and cost of probing gene expression on a large scale. The team created a tool that takes advantage of new high-throughput DNA sequencing technologies to make it easier to simultaneously measure gene activity in large numbers of cells or tissues.
Current peanut allergy tests are not very reliable when it comes to diagnosing the severity of an individual’s allergic reaction, which can range from hives to life-threatening anaphylactic shock. With an estimated three million people in the U.S. allergic to peanuts and tree nuts, having a more precise and reliable allergy test could prevent hospitalizations and allow for better monitoring of individuals suffering from peanut allergies.
When diagnosing a case of Ebola, time is of the essence. However, existing diagnostic tests take at least a day or two to yield results, preventing health care workers from quickly determining whether a patient needs immediate treatment and isolation. A new test could change that: The device, a simple paper strip similar to a pregnancy test, can rapidly diagnose Ebola, as well as other viral hemorrhagic fevers.
Federal health officials are easing access to DNA tests used to screen parents for devastating genetic disorders that can be passed on to their children. The surprise announcement offers a path forward for Google-backed genetic testing firm 23andMe, which previously clashed with regulators over its direct-to-consumer technology.
Many people imagine robots today as clunky, metal versions of humans, but scientists are forging new territory in the field of “soft robotics”. One of the latest advances is a flexible, microscopic hand-like gripper. The development could help doctors perform remotely guided surgical procedures or perform biopsies. The materials also could someday deliver therapeutic drugs to hard-to-reach places.
Farmers have long noted a correlation between rainstorms and disease outbreaks among plants. Fungal parasites known as “rust” can grow particularly rampant following rain events, eating away at the leaves of wheat and potentially depleting crop harvests. While historical weather records suggest rainfall may scatter rust and other pathogens throughout a plant population, the mechanism by which this occurs has not been explored, until now.
Reducing the use of laboratory animals has been a long-term goal in biological research. Many in vivo assays, like rabbit endotoxin testing or mouse antibody production testing to detect viral contaminants have largely been replaced by in vitro enzyme or PCR-based assays.
Patients with sickle cell disease often suffer from painful attacks known as vaso-occlusive crises, during which their sickle-shaped blood cells get stuck in tiny capillaries, depriving tissues of needed oxygen. Blood transfusions can sometimes prevent such attacks, but there are currently no good ways to predict when a vaso-occlusive crisis, which can last for several days, is imminent.
New York Univ. Polytechnic School of Engineering professors have been collaborating with researchers from Peking Univ. on a new test strip that is demonstrating great potential for the early detection of certain heart attacks. The new colloidal gold test strip can test for cardiac troponin I (cTn-I) detection.
Scientists have developed the first ultra-thin, flexible device that sticks to skin like a rub-on tattoo and can detect a person’s glucose levels. The sensor, reported in a proof-of-concept study in Analytical Chemistry, has the potential to eliminate finger-pricking for many people with diabetes.
Scientists from The Scripps Research Institute have identified a novel synthetic compound that sharply inhibits the activity of a protein that plays an important role in in the progression of breast and pancreatic cancers. In the new study the scientists showed that the compound, known as SR1848, reduces the activity and expression of the cancer-related protein called “liver receptor homolog-1” or LRH-1.
A group led by scientists has developed a new method for effectively extracting and analyzing cancer cells circulating in patients’ blood. Circulating tumor cells are cancer cells that break away from tumors and travel in the blood, looking for places in the body to grow new tumors called metastases. Capturing these rare cells would allow doctors to detect and analyze the cancer so they could tailor treatment for individual patients.
HIV can be treated, but not every infection responds the same way. Treatment requires monitoring and testing, a practice that can become expensive for health care systems in the developing world.
The project, “Testing Saves Lives,” asked community organizations that provide HIV testing services across China to submit videos on the importance of getting tested. The videos were judged based on whether they generated interest about HIV testing, proposed ways to reach untested individuals and engaged the community.
No methods currently exist for the early detection of Alzheimer’s disease, which affects one out of nine people over the age of 65. Now, an interdisciplinary team of Northwestern University scientists and engineers has developed a noninvasive MRI approach that can detect the disease in a living animal. And it can do so at the earliest stages of the disease, well before typical Alzheimer’s symptoms appear.
A team of scientists from Arizona State Univ.’s Biodesign Institute and IBM’s T.J. Watson Research Center have developed a prototype DNA reader that could make whole genome profiling an everyday practice in medicine. Such technology could help usher in the age of personalized medicine, where information from an individual’s complete DNA and protein profiles could be used to design treatments specific to their individual makeup.
Flexible electronic sensors based on paper have the potential to cut the price of a wide range of medical tools, from helpful robots to diagnostic tests. Scientists have now developed a fast, low-cost way of making these sensors by directly printing conductive ink on paper.
A new bloodstream infection test created by Univ. of California, Irvine researchers can speed up diagnosis times with unprecedented accuracy, allowing physicians to treat patients with potentially deadly ailments more promptly and effectively. The technology, called Integrated Comprehensive Droplet Digital Detection, or IC 3D, can detect bacteria in milliliters of blood with single-cell sensitivity in 90 mins; no cell culture is needed.
Researchers led by David Thompson, president of Aten Biotherapeutics and a professor in Purdue's Department of Chemistry, are developing controlled-release imaging agents that allow for a longer, safer imaging session.
Paramedics respond to a 911 call to find an elderly patient who’s having difficulty breathing. Anxious and disoriented, the patient has trouble remembering all the medications he’s taking, and with his shortness of breath, speaking is difficult. Is he suffering from acute emphysema or heart failure? Initiating the wrong treatment regimen will increase the patient’s risk of severe complications.
- Page 1